Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events-Reference-Cited by-同舟云学术

Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events

Published:2013-08-22 Issue:3 Volume:27 Page:241-248
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

van Rijt Willem G.¹²,van Goor Harry²,Ploeg Rutger J.³,Leuvenink Henri G. D.¹

Affiliation:

1. Department of Surgery; University of Groningen and University Medical Center Groningen; Groningen The Netherlands

2. Department of Pathology and Medical Biology; University of Groningen and University Medical Center Groningen; Groningen The Netherlands

3. Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12174/fullpdf

Reference58 articles.

1. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis;Yarlagadda;Nephrol Dial Transplant,2009

2. Oosterlee A Rahmel A Annual Report 2011 2011

3. Kidney transplantation from donors after cardiac death: a 25-year experience;Snoeijs;Transplantation,2010

4. Long-term renal allograft survival in the United States: a critical reappraisal;Lamb;Am J Transplant,2011

5. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial;Kidney International Reports;2024-02

2. Low-Dose Erythropoietin Amplifies Beneficial Effects of Angiotensin II Blockade on Glomerulosclerosis;Laboratory Investigation;2023-02

3. Linking erythropoietin to Treg-dependent allograft survival through myeloid cells;JCI Insight;2022-05-23

4. Co-treatment with Esculin and erythropoietin protects against renal ischemia–reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation;Scientific Reports;2022-04-14

5. Cytoprotective effects of erythropoietin: What about the lung?;Biomedicine & Pharmacotherapy;2021-07